Design, synthesis and structure-activity relationship study of wollamide B; a new potential anti TB agent

• Henok Asfaw,

  Affiliation Institut für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany

  http://orcid.org/0000-0003-1310-6691

  ⨯
• Katja Laqua,

  Affiliation Institut für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany

  ⨯
• Anna Maria Walkowska,

  Affiliation Institut für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany

  ⨯
• Fraser Cunningham,

  Current address: Cytokine, Chemokine & Complement DPU Immunoinflammation TA Unit, GSK Medicines Research Centre, GlaxoSmithKline, Stevenage, United Kingdom

  Affiliation Diseases of the Developing World, Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Maria Santos Martinez-Martinez,

  Affiliation Diseases of the Developing World, Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Juan Carlos Cuevas-Zurita,

  Affiliation Diseases of the Developing World, Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Lluís Ballell-Pages,

  Affiliation Diseases of the Developing World, Medicines Development Campus, GlaxoSmithKline, Tres Cantos, Madrid, Spain

  ⨯
• Peter Imming

  * E-mail: peter.imming@pharmazie.uni-halle.de

  Affiliation Institut für Pharmazie, Martin-Luther-Universität Halle-Wittenberg, Halle (Saale), Germany

  ⨯